Doceree forms Strategic Partnership with The Ward Marketing Group to Strengthen Its Global Footprint; Expands into Australian Market

October 23, 2024 05:48 PM IST | By Cision
 Doceree forms Strategic Partnership with The Ward Marketing Group to Strengthen Its Global Footprint; Expands into Australian Market
Image source: Kalkine Media

Expanding its reach from 22 markets to include Australia, Doceree partners with The Ward Marketing Group to enhance HCP-patient engagement in the region through innovative marketing solutions.

SYDNEY, Oct. 23, 2024 /PRNewswire/ -- Doceree, the world's first global network of physician-only platforms for programmatic messaging, today announced a strategic partnership with The Ward Marketing Group (Ward6, Ward7, The Engagement Ward & 66 South Research), Australia's largest healthcare marketing services company. The partnership brings Doceree to the Australian market as it expands into more geographies to change how pharmaceutical companies can engage healthcare professionals (HCPs) across the globe through pioneering digital marketing solutions.

Doceree partners with The Ward Marketing Group
Doceree partners with The Ward Marketing Group

The partnership between Doceree and The Ward Marketing Group will provide unparalleled abilities to the Australian healthcare market, empowering pharmaceutical companies with precise, scalable, and compliant messaging to HCPs. This collaboration with the proprietary AI-powered platform from Doceree will bridge the gap between pharmaceutical brands and doctors to enhance engagement by the use of data-driven, programmatic messaging solutions.

"We are thrilled to partner with The Ward Marketing Group, a leader in healthcare communications in Australia. This collaboration is a significant step in our global expansion strategy, enabling us to extend our innovative digital marketing solutions to the Australian market. Together, we will empower pharmaceutical brands to engage with healthcare professionals more effectively, ultimately driving better healthcare outcomes," said Harshit Jain MD, Founder & Global CEO of Doceree.

"Our partnership with Doceree represents a major advancement in how pharmaceutical companies in Australia can connect with HCPs. Doceree's expertise in programmatic marketing, combined with our deep understanding of the local healthcare landscape, will create new opportunities for more cost efficient, effective and compliant communications that can be measured and optimised in real time. We look forward to working closely with Doceree to deliver exceptional value to our clients and the wider healthcare community," added Stuart Black, CEO of The Ward Marketing Group.

This partnership will enable the pharmaceutical companies to send their message to the right professionals at the right time, delivering improved performance and measurable outcomes in their digital campaigns. Now, with the help of Doceree, The Ward Marketing Group can provide clients with better and more tightly targeted solutions in all their HCP communications.

This alliance is part of Doceree's broader strategy to expand its global footprint, following successful launches in North America, Europe, and Southeast Asia. The company continues to lead the way in digital healthcare marketing, offering unparalleled solutions that drive meaningful connections between pharmaceutical companies and healthcare professionals worldwide.

About Doceree

Leading the way in making HCP-patient conversations richer and more meaningful through patented, responsive technology, Doceree addresses both current and emerging challenges for healthcare and life sciences organizations in HCP-patient engagement, particularly where digital and technological advancements play a crucial role. Doceree leverages its patented technology to ensure that HCP-patient conversations and interactions are more meaningful, richer, and outcome-oriented. Learn more: www.doceree.com

About The Ward Marketing Group

The Ward Marketing Group is Australia's largest healthcare marketing services company. The Group includes two of Australia's leading and most awarded creative and scientific communication agencies, Ward6 and Ward7, along with media, data and marketing technology specialist The Engagement Ward (TEW), innovative learning and education platform TLL, and healthcare insight and research specialist 66South.

The Ward Marketing Group is set up with a demand-responsive architecture which means that expertise can be drawn from across The Group – the right people, with the right skills at the right time, exactly when our clients need them – to create customised solutions, while ensuring team separation for effective conflict management. This means outcomes and operational efficiencies are always optimised for the Group's clients.

The Ward Marketing Group's goal is to create ideas that create change for the better; to advance the health of people, communities, healthcare systems and the brands we work with, through bringing together insight, ideas and innovation.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.